Navigation Links
Mylan Announces Final FDA Approval for Zaleplon Capsules
Date:6/9/2008

PITTSBURGH, June 9 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.

Zaleplon Capsules are the generic version of King Pharmaceuticals' Sonata(R) Capsules, which had U.S. sales of approximately $88 million for the 12 months ending March 31, 2008, according to IMS Health.

This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand.

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
2. Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
3. Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
4. Mylan Declares Quarterly Preferred Stock Dividend
5. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
6. Mylan Announces Final FDA Approval for Trandolapril Tablets
7. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
8. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
9. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
10. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
11. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...letters from the North Pole, Textsanta.net lets pa...Santa , North Pole, AK (P...ciencies at the North Pole Santa Claus has added S...he globe informed of his Christmas progress at the...epartment have identified a large and growing perc...
(Date:11/26/2009)... Triangle Dental (RTDental), a leading dental grou...ced the expansion of its services to include LUMIN...millan. , Durham, NC (...nnounce that Dr. Doug Macmillan, an experienced L...l advanced training seminar. RTDental’s abi...
(Date:11/26/2009)...mp; Ennis, P.A. is offering free nationwide confid...irth control pills who have suffered a Deep Vein T... Attack or other related cardiac issues or had the...t 1-800-856-6405 or go to the firm’s website...ne case evaluation form. , ...
(Date:11/25/2009).... 25 The Bartle Hall Convention Ce...medical clinic on Dec. 9-10, when Kansas City host...or uninsured people. ,, "This free clinic event...use it will extend over two days instead of just o...nd," Sheri Wood, executive director of the Kansas ...
(Date:11/25/2009)...RNewswire/-SentinelleMedicalInc.,aleadingmanufactu...andCalgaryScientificInc.,aleadingproviderofsoftwar...egis(TM)Breast4DAdvancedVisualizationsoftware. ,...printWebclientbasedmedicalimagingofferinginthemark...zero-footprintaccess-requiringnosoftwaredownload,a...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... , DETROIT, May 14 Caraco Pharm...as recently launched oxycodone hydrochloride table..., a subsidiary of Sun Pharmaceutical Industries Lt...tion (ANDA) for generic Roxicodone(R) tablets. , ...
...n Hancock Long-Term Care (LTC) Insurance has selec...thcare services with more than 15 years of experie...d caregiver support services programs for its poli...nd group LTC insurance products, which allow polic...
...G, Pa., May 14 /PRNewswire-Asia-FirstCall/ -- BMP ...one" or the "Company") today announced,that the Co...l results on,Monday, May 18, 2009, after the marke... call by dialing,1-888-679-8034 or 1-617-213-4847 ...
...a., May 14 ECRI Institute Patient Safety Organiza...h the Coalition for Quality & Patient Safety (... data collection, reporting, and analysis. The Chi...S will coordinate its PSO and other patient safety...
...Cincinnati houses internationally and nationally r.... , And faculty and students from these cutting-e...better hospital gowns in partnership with Hill-Rom...ersity model headquartered at UC called the Live W...
...eating a common heart rhythm disorder by burning h...ter than drug treatments, a major international st...tment called catheter ablation, 63 percent of pati...of those treated with drugs were arrhythmia-free. ...
Other Medicine News:Health News:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets 2Health News:John Hancock Selects CHCS Services to Manage Long-Term Care Insurance Provider Discount and Caregiver Programs 2Health News:John Hancock Selects CHCS Services to Manage Long-Term Care Insurance Provider Discount and Caregiver Programs 3Health News:John Hancock Selects CHCS Services to Manage Long-Term Care Insurance Provider Discount and Caregiver Programs 4Health News:BMP Sunstone To Report First Quarter 2009 Financial Results 2Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 2Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 3Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 4Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 5Health News:UC design innovation: New hope for the hated hospital gown 2Health News:UC design innovation: New hope for the hated hospital gown 3Health News:UC design innovation: New hope for the hated hospital gown 4Health News:UC design innovation: New hope for the hated hospital gown 5Health News:UC design innovation: New hope for the hated hospital gown 6Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 2Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 3
(Date:11/24/2009)..., Nov. 24 /PRNewswire-Asia/ -- Chindex Internation...ndependent American provider of Western,healthcare... China, today,announced that the Company will atte...h Care Conference, to be held December 1 - 2, 2009...ent is currently scheduled to present at 11:30 am ...
(Date:11/24/2009)... 24 Quest Diagnostics In...vider of diagnostic testing, information and servi...e 21st Annual Piper Jaffray Healthcare Conference ...or Wednesday, December 2, 2009 at 9:30 a.m. Easter...ill reaffirm its 2009 guidance for revenue growth ...
(Date:11/24/2009)... and NEW YORK, Nov. 24 Eisai Inc...d and Drug Administration (FDA) has accepted for r...daily 23 mg Aricept® (donepezil HCl extended ...severe Alzheimer,s disease (AD). This new higher ...n an extended release, matrix-type tablet with a d...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH 075 28NorLevo 28R 29 29 5894 1Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH 075 28NorLevo 28R 29 29 5894 2Pharmasset to Webcast an Investor Event from the AASLD Meeting 14676 1Pharmasset to Webcast an Investor Event from the AASLD Meeting 14676 2Pharmasset to Webcast an Investor Event from the AASLD Meeting 14676 3Pharmasset to Webcast an Investor Event from the AASLD Meeting 14676 4For People on Dialysis Too Thin Can Be Risky 60477 1
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: